MA
62
4
HIG
70
2
NEM
56
-3
AEE
76
3
EXR
48
6
BAX
39
4
HSIC
51
6
AAP
20
2
PLD
43
3
DVN
31
4
MCHP
39
2
COP
33
5
BXP
41
2
NI
67
5
DE
55
12
EMC
47
5
ESS
40
3
EXPD
34
5
PEP
38
5
DIS
61
3
MA
62
4
HIG
70
2
NEM
56
-3
AEE
76
3
EXR
48
6
BAX
39
4
HSIC
51
6
AAP
20
2
PLD
43
3
DVN
31
4
MCHP
39
2
COP
33
5
BXP
41
2
NI
67
5
DE
55
12
EMC
47
5
ESS
40
3
EXPD
34
5
PEP
38
5
DIS
61
3
Financhill
Back

Madrigal Pharmaceuticals Stock Predictions

Market's down 10% YTD Buffet's Berkshire up 13%

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

MDGL
Madrigal Pharmaceuticals

Last Price:
$301.10
Seasonality Move:
9.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Madrigal Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 39.7% based on the past 18 years of stock performance.
  • Madrigal Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Madrigal Pharmaceuticals Stock Undervalued?
    The current Madrigal Pharmaceuticals [MDGL] share price is $301.66. The Score for MDGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Madrigal Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 39.7% based on the past 18 years of stock performance.

Madrigal Pharmaceuticals Stock Rating

Sell
47
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals overpriced?

  • Madrigal Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Madrigal Pharmaceuticals Stock Price History

Is MDGL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com

52-Week Data

52-Week High:
377.46
52-Week Low:
189.00

Prediction Charts

Market Cap:
6.7B
Price in USD:
301.66
Volume:
238.6K
Beta:
1.11

Technical Analysis

SMA50:
330.73
SMA100:
323.37
SMA200:
289.50
52-Wk Change:
32.11%

Stock Predictions

  • Is Madrigal Pharmaceuticals stock public?
    Yes, Madrigal Pharmaceuticals is a publicly traded company.
  • What is the Madrigal Pharmaceuticals stock quote today?
    The Madrigal Pharmaceuticals stock price is 301.66 USD today.
  • How to buy Madrigal Pharmaceuticals stock online?
    You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-31 317.62 331.23 333.00 310.00
Apr-1 331.76 323.98 334.93 320.70
Apr-2 321.75 334.60 341.91 318.32
Apr-3 321.19 327.10 335.29 320.00
Apr-4 318.69 314.39 325.09 309.00
Apr-7 299.35 310.52 321.59 290.50
Apr-8 323.64 302.78 325.81 300.22
Apr-9 296.25 313.95 333.32 289.99
Apr-10 306.43 307.35 313.00 294.00
Apr-11 309.38 317.15 324.14 304.06
Apr-14 324.54 322.32 327.85 316.70
Apr-15 324.44 321.10 330.64 314.74
Apr-16 309.00 307.78 313.59 292.49
Apr-17 306.13 301.66 306.81 298.36

Madrigal Pharmaceuticals Earnings

Madrigal Pharmaceuticals Earnings Report: Per Share Madrigal Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Madrigal Pharmaceuticals Forecast Revenue Growth

Madrigal Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $4.02 per share, a decrease next quarter of $2.11 per share, an increase this year of $11.00 per share, and an increase next year of $13.99 per share.

* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.